Clover Health ex-officer to sell 215K shares

CLOVER HEALTH INVESTMENTS, CORP.

Rhea-AI Filing Summary

CLOVER HEALTH INVESTMENTS, CORP. (CLOV) received a notice that former officer Brady Priest intends to sell up to 215,291 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of $999,574.58 as of September 15, 2026.

The notice also lists prior sales of CLOV common stock by Brady Priest during the preceding three months totaling several hundred thousand shares.

Key Figures

Shares to be sold under Rule 144: 215,291 shares Aggregate market value of planned sale: $999,574.58 Shares sold on August 31, 2026: 73,516 shares +5 more

8 metrics

Shares to be sold under Rule 144 215,291 shares Maximum CLOV common shares listed in the current Rule 144 notice

Aggregate market value of planned sale $999,574.58 Value for 215,291 CLOV common shares as of September 15, 2026

Shares sold on August 31, 2026 73,516 shares CLOV common stock sold by Brady Priest during prior three months

Proceeds on August 31, 2026 sale $305,113.45 Sale of 73,516 CLOV common shares

Shares sold on August 14, 2026 474,801 shares CLOV common stock sold by Brady Priest during prior three months

Proceeds on August 14, 2026 sale $2,171,597.33 Sale of 474,801 CLOV common shares

Shares sold on August 7, 2026 441,601 shares CLOV common stock sold by Brady Priest during prior three months

Proceeds on August 7, 2026 sale $2,141,988.87 Sale of 441,601 CLOV common shares

Key Terms

Rule 144, restricted stock, Former Officer

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock financial

"Common | 07/18/2023 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Former Officer financial

"Former Officer 144: Securities Information"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for CLOV?

It discloses that former officer Brady Priest has notified of an intended sale of up to 215,291 shares of Clover Health Investments, Corp. common stock under Rule 144, with an indicated aggregate market value of $999,574.58 as of September 15, 2026.

How many CLOV shares does Brady Priest plan to sell under this notice?

Brady Priest plans to sell up to 215,291 shares of Clover Health Investments, Corp. common stock, as stated in the Rule 144 securities information section.

What is the reported market value of the CLOV shares to be sold?

The Rule 144 notice lists an aggregate market value of $999,574.58 for the 215,291 shares of Clover Health Investments, Corp. common stock covered by the planned sale as of September 15, 2026.

Which broker is handling the planned CLOV stock sale?

The planned sale of 215,291 CLOV common shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, in the Rule 144 securities information section.

What CLOV share sales has Brady Priest made in the past three months?

The notice lists prior sales of CLOV common stock by Brady Priest of 73,516 shares for $305,113.45 on August 31, 2026; 474,801 shares for $2,171,597.33 on August 14, 2026; and 441,601 shares for $2,141,988.87 on August 7, 2026.

What type of CLOV securities are covered by this Form 144?

The notice covers common stock of Clover Health Investments, Corp., originally issued as restricted stock on July 18, 2023, now being reported for potential resale under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 05:10 PM Accepted by SEC EDGAR 09/15/2026 - 05:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001938197
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CLOVER HEALTH INVESTMENTS, CORP.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	(201) 432-2133
Name of Person for Whose Account the Securities are To Be Sold	BRADY PRIEST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	215291	999574.58	435441337	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/18/2023	Restricted Stock	Issuer			215291	07/18/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRADY PRIEST 1209 Orange Street Wilmington DE 19801	Common	08/31/2026	73516	305113.45
BRADY PRIEST 1209 Orange Street Wilmington DE 19801	Common	08/14/2026	474801	2171597.33
BRADY PRIEST 1209 Orange Street Wilmington DE 19801	Common	08/07/2026	441601	2141988.87

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brady Patrick Priest
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)